FDA has issued at least five warning letters in October to marketers of sunscreen wipes and other dosage formats considered ineligible for OTC sunscreen drug review, making their offerings unapproved drugs.
Recipients include Colabs Intl. Corp., Diamond Wipes International, Inc., ITW Dymon, SCS Direct Inc. (the holding company of MD MOMS LLC) and PhytoCeuticals, Inc., according to the
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?